NIH-funded research NIH-funded research

Creating new methods to build complex bioactive molecules and protein conjugates

Official title: Novel Acylborons and Alpha-hydroxy Borons to Enable Modular, Regio- and Stereocontrolled Synthesis of Bioactive Molecules and Protein Conjugates

Funded at The Trustees of the Stevens Institute of Technology · NIH-10877095 · Data updated 2026-11-12

This study is exploring new ways to create special molecules that could help develop better medicines, which might lead to new treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionThe Trustees of the Stevens Institute of Technology
NIH-funded
Lab location1 site (Hoboken, United States)
Project startAugust 1, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$373,865
NIH project number5R35GM143091-04
Project IDNIH-10877095 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals with conditions that could be treated by novel bioactive molecules or protein conjugates.

Less likely to help

Patients with conditions that do not involve the need for new drug development or those not affected by the types of molecules being synthesized may not receive any benefit.

What this research studies

This research focuses on developing innovative strategies to synthesize complex molecules that can be used in medicine. By using modular synthetic techniques, the project aims to create new types of organoborons, which are important building blocks for bioactive compounds. The approach involves constructing these molecules in a controlled manner to enhance their biological activity, potentially leading to new therapeutic options. Patients may benefit from advancements in drug discovery and development stemming from these novel compounds.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and more effective drugs for various medical conditions.

How similar studies have gone: While the specific approach of using acylborons is relatively novel, similar modular synthesis strategies have shown promise in other areas of drug discovery.

Where this research is happening

  • The Trustees of the Stevens Institute of Technology
    Hoboken, United States
    Active

Researchers

  • Principal investigator: Sharma, Abhishek — The Trustees of the Stevens Institute of Technology
  • Study coordinator: Sharma, Abhishek

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.